We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 6,255 results
  1. Unlocking new avenues for neuropsychiatric disease therapy: the emerging potential of Peroxisome proliferator-activated receptors as promising therapeutic targets

    Rationale

    Peroxisome proliferator-activated receptors (PPARs) are transcription factors that regulate various physiological processes such as...

    Asmita Deka Dey, Ashi Mannan, ... Thakur Gurjeet Singh in Psychopharmacology
    Article 27 May 2024
  2. The Strategy of Targeting Peroxisome Proliferator-Activated Receptor (PPAR) in the Treatment of Neuropsychiatric Disorders

    Peroxisome proliferator-activated receptors (PPARs) are nonsteroid nuclear receptors and transcription factors that regulate several...
    Chapter 2023
  3. Peroxisome proliferator-activated receptor α agonist induces mouse hepatomegaly through the spatial hepatocyte enlargement and proliferation

    Peroxisome proliferator-activated receptor alpha (PPARα) activation-induced hepatomegaly is accompanied by hepatocyte hypertrophy around the central...

    Jie Yang, **ao Yang, ... Hui-chang Bi in Acta Pharmacologica Sinica
    Article 16 May 2023
  4. Cardiomyocyte peroxisome proliferator-activated receptor α prevents septic cardiomyopathy via improving mitochondrial function

    Clinically, cardiac dysfunction is a key component of sepsis-induced multi-organ failure. Mitochondria are essential for cardiomyocyte homeostasis,...

    **n-xin Zhu, **a Wang, ... Ai-juan Qu in Acta Pharmacologica Sinica
    Article 16 June 2023
  5. Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1Alpha (PGC-1α): A Transcriptional Regulator at the Interface of Aging and Age-Related Macular Degeneration?

    Human age-related macular degeneration (AMD) is a prevalent age-related disease which causes retinal dysfunction and disability. Genetic and cell...
    Conference paper 2023
  6. Relationship of Sulfatides Physiological Function and Peroxisome Proliferator-Activated Receptor α

    Sulfatides are unique sphingolipids present in the serum and the plasma membrane. Sulfatides exert important functions in a number of systems in the...

    Tong-tong Li, Gang Li, ... Yun-ting Shao in Neurochemical Research
    Article 06 March 2023
  7. Effect of Rosiglitazone, the Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, on Apoptosis, Inflammatory Cytokines and Oxidative Stress in pentylenetetrazole-Induced Seizures in Kindled Mice

    A growing body of evidence has shown that seizure can trigger inflammatory cascades through increasing the expression of several inflammatory...

    **liang Li, Su** Chen, ... Abolfazl Amini in Neurochemical Research
    Article 19 May 2023
  8. Regulation of tight junction proteins and cell death by peroxisome proliferator-activated receptor γ agonist in brainstem of hypertensive rats

    The decrease in tight junction proteins and their adapter proteins in the hypertensive brain is remarkable. Here, we aimed to investigate tight...

    Nazlıcan Şeren, Ima Dovinova, ... Güliz Armagan in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 17 July 2023
  9. Peroxisome proliferator activated receptor-gamma (PPAR-γ) ligand, pioglitazone, increases analgesic and anti-inflammatory effects of naproxen

    The aim of this study was the investigation of analgesic and anti-inflammatory activity of naproxen and pioglitazone following intra-plantar...

    Rasool Haddadi, Mohammad Cheraghi-poor in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 12 September 2023
  10. Ligand-Independent Coactivation of Peroxisome Proliferator-Activated Receptor Gamma

    The peroxisome proliferator-activated receptors (PPARs) are related transcription factors in the nuclear hormone receptor family. The regulation of...
    Robert G. Bennett in Nuclear Receptors
    Chapter 2021
  11. Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Levels in Adolescent with Bipolar Disorder and Their Relationship with Metabolic Parameters

    Peroxisome proliferator-activated receptor gamma (PPARγ) is one of the immune and metabolic regulatory agents. This study examined the serum PPARγ...

    Meryem Kasak, Mehmet Fatih Ceylan, ... Özcan Erel in Journal of Molecular Neuroscience
    Article 23 March 2022
  12. Regulation of adipogenesis through retinoid X receptor and/or peroxisome proliferator-activated receptor by designed lignans based on natural products in 3T3–L1 cells

    We previously synthesized two retinoid X receptor (RXR) agonists, 4′-hydroxy-3′-propyl-[1,1′-biphenyl]-3-propanoic acid ethyl ester (4′OHE) and...

    Ken-ichi Nakashima, Marina Okamura, ... Makoto Inoue in Journal of Natural Medicines
    Article 06 January 2023
  13. Addressing Peroxisome Proliferator-Activated Receptor-gamma in 3-Nitropropionic Acid-Induced Striatal Neurotoxicity in Rats

    Telmisartan (TEL) is an angiotensin II type 1 receptor blocker and a partial activator of peroxisome proliferator-activated receptor-gamma (PPARγ),...

    Riham M. Mansour, Nesrine S. El Sayed, ... Ayman E. El-Sahar in Molecular Neurobiology
    Article Open access 12 May 2022
  14. Peroxisome Proliferator-Activated Receptor-Gamma (PPAR-ɣ): Molecular Effects and Its Importance as a Novel Therapeutic Target for Cerebral Ischemic Injury

    Cerebral ischemic injury is a leading cause of death and long-term disability throughout the world. Peroxisome proliferator-activated receptor gamma...

    Ashi Mannan, Nikhil Garg, ... Harmeet Kaur Kang in Neurochemical Research
    Article 20 July 2021
  15. In vivo study revealed pro-tumorigenic effect of CMTM3 in hepatocellular carcinoma involving the regulation of peroxisome proliferator-activated receptor gamma (PPARγ)

    Purpose

    To clarify the ambiguity of the function of CMTM3 in the development of hepatocellular carcinoma (HCC) and explore its molecular mechanism.

    ...
    Jiahui Wang, Hong** Chu, ... Fujun Liu in Cellular Oncology
    Article 26 October 2022
  16. Peroxisome proliferator-activated receptor-γ doesn’t modify altered electrophysiological properties of the CA1 pyramidal neurons in a rat model of hepatic cirrhosis

    Regarding the low quality of life due to the cognitive complications in the patients with hepatic cirrhosis (HC), the goal of this study was to...

    Mahshid Tahamtan, Iraj Aghaei, ... Moazamehosadat Razavinasab in Metabolic Brain Disease
    Article 09 August 2022
  17. Nuclear Receptors and Lipid Sensing

    Fluctuations in concentration of diverse lipid classes occur in response to diet and metabolism. These changes are managed and mediated by a cell...
    James L. Thorne, Giorgia Cioccoloni in Nuclear Receptors in Human Health and Disease
    Chapter 2022
  18. The peroxisome: an update on mysteries 3.0

    Peroxisomes are highly dynamic, oxidative organelles with key metabolic functions in cellular lipid metabolism, such as the β-oxidation of fatty...

    Rechal Kumar, Markus Islinger, ... Michael Schrader in Histochemistry and Cell Biology
    Article Open access 20 January 2024
  19. Perfluoroalkyl Substances (PFAS) and Their Effects on the Placenta, Pregnancy, and Child Development: a Potential Mechanistic Role for Placental Peroxisome Proliferator–Activated Receptors (PPARs)

    Purpose of Review

    This review summarizes studies highlighting perfluoroalkyl substances (PFAS) and their effects on the placenta, pregnancy outcomes,...

    John T. Szilagyi, Vennela Avula, Rebecca C. Fry in Current Environmental Health Reports
    Article 18 August 2020
Did you find what you were looking for? Share feedback.